K141532

Substantially Equivalent

CR3 KEYLESS SPLIT SAMPLE CUP AMPHETAMINE-COCAINE

Applicant: Guangzhou Wondfo Biotech Co., Ltd.
Product code: DKZ
Advisory panel: Clinical Toxicology
Date received: 2014-06-10
Decision date: 2014-07-14
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Gaithersburg, MD, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.